Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture

European Journal of Endocrinology

Volumn 137, Issue 2, 1997, Pages 193-199

  Barreca, Antonina M ^a   Voci, Adriana ^a   Lee, Phillip D K ^b   Arvigo, Marica ^a   Ghigliotti, Valeria ^a   Fugassa, Emilia ^a   Giordano, Giulio ^a   Minuto, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Diagnostic Systems Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; HORMONAL REGULATION; KUPFFER CELL; LIVER CELL; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ACIDS; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, GEL; DRUG STABILITY; HORMONES; IMMUNOBLOTTING; LIVER; MALE; MOLECULAR WEIGHT; OCTREOTIDE; RATS; RATS, WISTAR; SOMATOMEDINS; SOMATOSTATIN;

EID: 0030822721     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370193     Document Type: Article

References (33)

1. Rechler M. Non-receptor-binding proteins for insulin-like growth factors and other cytokines: modulators of peptide action. In Molecular Endocrinology: Basic Concepts and Clinical Correlations, ch 12. pp 155-180. Ed BD Weintraub. New York: Raven Press Ltd. 1995.
2. Jones J & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34.
3. Shimasaki S & Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Progress in Growth Factor Research 1991 3 243-266.
4. Zapf J, Waldvogel M & Froesch ER. Binding of non-suppressible insulin-like activity to human serum. Evidence for a carrier protein. Archives of Biochemistry and Biophysics 1975 168 638-645.
5. Hintz RL & Liu F. Demonstration of specific plasma protein binding sites for somatomedin. Journal of Clinical Endocrinology and Metabolism 1977 45 988-995.
6. Furlanetto RW. The somatomedin C binding protein: evidence for a heterologous subunit structure. Journal of Clinical Endocrinology and Metabolism 1980 51 12-19.
7. Baxter RC. Characterization of the acid-labile subunit of the growth hormone dependent insulin-like growth factor binding protein complex. Journal of Clinical Endocrinology and Metabolism 1988 67 265-271.
8. Baxter RC, Martin JL & Beniac VA. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. Journal of Biological Chemistry 1989 264 11843-11848.
9. Leong SR, Baxter RC, Camerato T, Dai J & Wood WI. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Molecular Endocrinology 1992 6 870-876.
10. Chin E, Zhou J, Dai J, Baxter RC & Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994 134 2498-2504.
11. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJP & Hill DJ. Differential cellular synthesis of insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. Journal of Endocrinology and Metabolism 1994 79 1871-1876.
12. Villafuerte BC, Koop BL, Pao CI, Gu L, Birdsong GG & Phillips LS. Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor-binding protein-3 in vitro. Endocrinology 1994 134 2044-2050.
13. Thissen JP, Ketelslegers JM & Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Review 1994 15 80-101.
14. Barreca A, Voci A, Minuto F, de Marchis M, Cecchelli E, Fugassa E et al. Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Molecular and Cellular Endocrinology 1992 84 119-126.
15. Clemmons DR. Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. Journal of Endocrinology and Metabolism 1984 58 850-858.
16. Martin JL, Ballesteros M & Baxter RC. Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 1992 131 1703-1710.
17. Baxter RC. Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor binding protein complex. Journal of Clinical Endocrinology and Metabolism 1990 70 1347-1353.
18. Kupfer SR, Underwood LE, Baxter RC & Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. Journal of Clinical Investigation 1993 91 391-396.
19. Young SC, Underwood LE, Celniker A & Clemmons DR. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. Journal of Clinical Endocrinology and Metabolism 1992 75 603-608.
20. Dai J, Scott CD & Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 1994 135 1066-1072.
21. Boisclair YR, Seto D, Hsieh S, Hurst KR & Ooi GT. Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex. Proceedings of the National Academy of Sciences of the USA 1996 93 10028-10033.
22. Liu F, Hintz RL, Khare A, Diagustine RP, Powell DR & Lee PDK. Immunoblot studies of the IGF-related acid-labile subunit. Journal of Clinical Endocrinology and Metabolism 1994 79 1883-1886.
23. Barreca A & Minuto F. Somatomedins: chemical and functional characteristics of the different molecular forms. Journal of Endocrinological Investigation 1989 12 279-294.
24. 125I-IGF-I. Journal of Clinical Endocrinology and Metabolism 1995 80 1318-1324.
25. Dai J & Baxter RC. Molecular cloning of the acid-labile subunit of the rat insulin-like growth factor binding protein complex. Biochemical and Biophiysical Research Communications 1992 188 304-309.
26. Serri O, Brazeau P, Kachra Z & Posner B. Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology 1992 130 1816-1821.
27. Barreca A, Cariola G, Ponzani P, Arvigo M, Foppiani L, Giordano G & Minuto F. Effect of octreotide on circulating IGF-I chromatographie profile: evidence for an inhibitory action on the formation of the 150 kDa ternary complex. Clinical Endocrinology 1995 42 161-167.
28. Ren SG, Ezzat S, Melmed S & Braunstein GD. Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology 1992 131 2479-2481.
29. Hartshorn MA, Scott CD & Baxter RC. Immunofluorescent localization of type II insulin-like growth factor receptor in rat liver and hepatoma cells. Journal of Endocrinology 1989 121 221-227.
30. Martin JL & Baxter RC. Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 1991 128 1425-1433.
31. Schalch DS, Heinrich UE, Draznin B, Johnson CJ & Miller LL. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 1979 104 1143-1151.
32. Palmero S, Prati M, Barreca A, Minuto F, Giordano G & Fugassa E. Thyroid hormone stimulates the production of insulin-like growth factor-I (IGF-I) by immature Sertoli cells. Molecular and Cellular Endocrinology 1990 68 61-65.
33. Furlanetto RW, Underwood LE, Van Wyk JJ & D'Ercole AJ. The radioimmunoassay for somatomedin C. In Somatomedins and Growth, ch 23, pp 123-135. Eds G Giordano, JJ Van Wyk & F Minuto. London: Academic Press, Serono Symposia, 1979.